[ Price : $8.95]
Dyne Therapeutics reports positive topline results from its Phase 1/2 DELIVER trial of z-rostudirsen (DYNE-251), saying the invest...[ Price : $8.95]
Top House Democrats demand FDA provide documents and explanations after revelations that a senior FDA official circulated new vacc...[ Price : $8.95]
A biosimilars scholar files a citizen petition urging FDA to dramatically streamline and modernize its biosimilar approval require...[ Price : $8.95]
FDA approves Gamida Cells Omisirge, the first cellular therapy authorized to treat patients with severe aplastic anemia.[ Price : $8.95]
FDA postpones a promised safety review of the abortion drug mifepristone and is now not likely to be released until after the 2026...[ Price : $8.95]
A senior CDRH compliance official warns industry that persistent shortcomings in complaint handling, corrective actions, and medic...[ Price : $8.95]
FDA approves Juno Therapeutics CAR-T therapy lisocabtagene maraleucel (Breyanzi) for adults with relapsed or refractory marginal z...[ Price : $8.95]
Praxis Precision Medicines says its experimental epilepsy drug relutrigine produced positive results in a key study, prompting an ...